High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097. (Q39593637)
Jump to navigation
Jump to search
scientific article published on 21 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097. |
scientific article published on 21 January 2011 |
Statements
1 reference
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097. (English)
1 reference
Wei He
1 reference
Leopoldo Luistro
1 reference
Daisy Carvajal
1 reference
Melissa Smith
1 reference
Tom Nevins
1 reference
Xuefeng Yin
1 reference
James Cai
1 reference
Brian Higgins
1 reference
Kenneth Kolinsky
1 reference
Christine Rizzo
1 reference
Kathryn Packman
1 reference
David Heimbrook
1 reference
John F Boylan
1 reference
21 January 2011
1 reference
1 reference
Identifiers
1 reference